References
- Mauch P., Tarbell N., Weinstein H., Silver B., Goffman T., Osteen R., Zajac A., Coleman N. C., Canellos G., Rosenthal D. Stage IA and IIA Supradiaphragmatic Hodgkin's Disease: Prognostic Factors in Surgically Staged Patients Treated With Mantle and Paraaortic Irradiation. J. Clin. Oncol 1988; 6: 1576–1583
- Swerdlow A. J., Douglas A. J., Vaughan Hudson G., Vaughan Hudson B., Bennett M. H., MacClennan K. A. Risk of secondary primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. Br. Med. J 1992; 304: 1137–1142
- Horning S. J., Hoppe R. T., Hancock S. L., Rosenberg S. A. Vinblastine, Bleomycin and Methotrexate: An Effective Adjuvant in Favorable Hodgkin's Disease. J. Clin. Oncol 1988; 6: 1822–1831
- Gledhill S., Gallagher A., Jones D. B., Krajewski A. S., Alexander F. E., Klee E., Wright D. H., O'Brien C., Onions D. E., Jarrett R. F. Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples. Br. J. Cancer 1991; 64: 227–32
- Hoiby E. A., Tjade T., Rotterund O. J. Evaluation of ten commercial heterophile antibody tests for infectious mononucleosis. Act path, microbiol. imunol. scand. Sect. C 1985; 63: 145–151
- Wolff P., Dorfman R., McClenahan J., Collins F. False positive infectious mononucleosis spot in lymphoma. Cancer 1970; 25: 626–628
- Horwitz C., Henle W., Henle G., Penn G., Hoffman N., Ward P. Persistent falsely positive rapid tests for Infectious Mononucleosis. Report of five cases with four-five year follow up data. Am. J. Clin. Pathol 1979; 11: 807–811